Project Grant R01AI183392
Award Date
8/20/24
Completion Date
7/31/29
Dollars Obligated
$120K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
2135 N Keene Rd, Clearwater, FL 33763, USA
Similar Awards
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $769,366 to The Trustees of the University of Pennsylvania to conduct research focused on deciphering the development and maintenance of protective dermal resident memory CD4+ T cells that can protect against cutaneous leishmaniasis, a neglected vector-borne disease. The research aims to 1) determine if...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $137,229 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Chulalongkorn University in Thailand. The grant, which runs from August 2024 to July 2029, focuses on two key objectives: Characterizing the host response and identifying novel biomarkers to accurately predict the severity of acute leptospirosis, a potentially life-threatening zoonotic disease. This will involve a...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $730,392 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Colorado-Denver. The 5-year grant, awarded on Jun 17, 2025, supports research to investigate the role of adipose tissue and adipose eosinophils in regulating airway function and inflammation in lean and obese mouse models of asthma. The key objectives are to: 1) Determine the metabolic response of...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $155,686 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Baylor College of Medicine. The grant will fund a 2-year prospective study to identify high-performing screening strategies for strongyloidiasis, a parasitic infection caused by Strongyloides stercoralis, in at-risk populations in the U.S. The study aims to evaluate a panel of parasitological, serological, and molecular...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $182,084 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Wisconsin - Madison. The funding will support research to investigate the role of prostaglandin E2 in priming CD8+ T-cell responses against the bacterial pathogen Listeria monocytogenes. The project aims to identify bacterial determinants that induce prostaglandin E2 production and understand how this...
This federal Project Grant award of $451,292.00 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to uncover neuronal mechanisms that orchestrate metabolic adaptations to bacterial infections, with a focus on delineating the role of the brain-liver axis in modulating metabolic responses. The research seeks to identify neurocircuits in the hypothalamus that monitor circulating lipoproteins and...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $516,175 Project Grant under CFDA 93.855, Allergy and Infectious Diseases Research, to Seattle Children's Hospital/Seattle Children's Research Institute. The grant, effective June 23, 2025 through May 31, 2027, will fund research to evaluate the impact of pre-existing humoral immunity on hepatocyte death in the context of malaria infection. The research aims to understand how non-neutralizing antibodies that bind...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $541,500 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the San Diego Biomedical Research Institute. The grant supports research investigating the relationship between calorie restriction, core body temperature, and autoimmunity in lupus mouse models. Key objectives include studying the effects of calorie restriction and thermoneutral housing conditions on circadian...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $711,993 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Boston Medical Center Corporation (BMC) on June 11, 2025. The grant supports research to understand the effects of Mycobacterium tuberculosis (MTB) disease on HIV-1 pathogenesis, immunity, and persistence in people living with HIV. Specifically, the project will assess how MTB disease impacts the HIV-1 immune response,...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $299,933 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to L2 Diagnostics LLC, a for-profit biomedical research company based in Woodbridge, Connecticut. The project aims to develop a novel therapeutic using a secretory leukocyte protease inhibitor (SLPI) to mitigate Lyme arthritis and post-treatment Lyme disease syndrome. The award period runs from July 8, 2024 to June 30, 2026....